Home › Funds › New Vernon Capital Holdings II LLC › HRMY

New Vernon Capital Holdings II LLC position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

New Vernon Capital Holdings II LLC reported holding 6,983 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q3 2026 13F filing — a position valued at US$274K, representing 0.17% of its reported portfolio and ranking #33 among its reported holdings. New Vernon Capital Holdings II LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)6.98K sh
Reported value held$274.15K
Portfolio Weight0.17%
First reportedQ4 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How New Vernon Capital Holdings II LLC's HRMY position evolved

New Vernon Capital Holdings II LLC first disclosed a stake in HRMY in Q4 2023 at 14,036 shares (US$453K). The position peaked in Q1 2025 at 488,424 shares, worth US$14.7M. Across 12 filings, New Vernon Capital Holdings II LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 6,983 shares valued at US$274K — an increase of 2,442 shares quarter over quarter.. Notable position changes include a 3219% increase in Q1 2025 (shares fell 5% over the following quarter), a 97% trim in Q2 2025 (shares fell 13% over the following quarter), a 69% trim in Q3 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 14.04K $453.36K New
Q1 2024 14.72K $494.16K Add
Q2 2024 14.72K $443.98K Hold
Q3 2024 14.72K $588.64K Hold
Q4 2024 14.72K $506.38K Hold
Q1 2025 488.42K $14.72M Add
Q2 2025 14.72K $465.03K Reduce
Q3 2025 4.54K $125.15K Reduce
Q4 2025 4.54K $169.92K Hold
Q1 2026 4.54K $127.19K Hold
Q2 2026 4.54K $165.34K Hold
Q3 2026 6.98K $274.15K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 38 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.4M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has New Vernon Capital Holdings II LLC held HRMY?

New Vernon Capital Holdings II LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is New Vernon Capital Holdings II LLC's current position in HRMY?

As of Q3 2026, New Vernon Capital Holdings II LLC holds 6.98K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $274.15K, representing 0.17% of its reported portfolio and ranking #33.

Has New Vernon Capital Holdings II LLC been buying or selling HRMY?

In the latest 13F filing (Q3 2026), New Vernon Capital Holdings II LLC increased its position in HRMY. The position peaked in Q1 2025 at 488.42K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.